Marca Nominativa depositada no INPI em 28/07/2021 por Aspira Women's Health, Inc., processo nº 501647245, nas classes 42, 44. Registro em vigor até 28/07/2031.
| Número do processo | 501647245 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 28/07/2021 |
| Data da concessão | 04/04/2023 |
| Vigência até | 28/07/2031 |
| Titular | Aspira Women's Health, Inc. |
| UF · País | — · US |
Providing on-line non-downloadable software for medical diagnostic testing in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; providing on-line non-downloadable software for gynecological diagnostic testing; providing on-line non-downloadable software for cancer diagnostic testing; providing on-line non-downloadable software for genetic testing; Software as a service (SAAS) services featuring software for medical diagnostic testing; Software as a service (SAAS) services featuring software for gynecological diagnostic testing; Software as a service (SAAS) services featuring software for cancer diagnostic testing; Software as a service (SAAS) services featuring software for genetic testing; Software as a service (SAAS) services featuring software using artificial intelligence for medical diagnostic testing; consulting services in the field of software as a service (SAAS); design and development of computer software for use in the healthcare field; implementation and maintenance of computer software for use in fields of healthcare, oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; providing on-line non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing temporary use of on-line non-downloadable software and applications using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; hosting a website featuring non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; hosting of platforms on the Internet for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing.;
Medical testing for diagnostic or treatment purposes in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; medical information services, namely, reporting of consumer authorized clinical testing results for clinical review; providing medical information to doctors and patients in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; medical analysis services for the diagnosis of cancer; providing medical information, consultancy and advisory services in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; DNA screening for medical purposes; medical diagnosis of cancer; medical diagnosis of ovarian cancer; medical diagnosis of breast cancer; medical diagnosis of endometriosis; genetic testing for medical purposes.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501647245 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.